Trial intelligence / Profile preview

Blood Pressure in Blacks and Calcium (BBC) and Vitamin D Study

NCT03070483Phase 2Completed

Sponsor
Loyola University Chicago
Start
Mar 2018
Primary completion
Nov 2018
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of vitamin d in hypertension (HTN) and Vitamin D deficiency (VDD), sponsored by Loyola University Chicago. Primary endpoint: Mean Blood Pressure at 12 weeks. Started Mar 2018; status: completed.

02

Drugs

vitamin d
03

Conditions

hypertension (HTN)Vitamin D deficiency (VDD)

Beyond the preview

Go deeper on NCT03070483.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03070483.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call